Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 1936 AL 1950

Connexin43- and Pannexin-Based Channels in Neuroinflammation and Cerebral Neuropathies

Sarrouilhe D, Dejean C, Mesnil M.

Front Mol Neurosci. 2017 Oct 10;10:320. doi: 10.3389/fnmol.2017.00320. eCollection 2017.

Falls in Parkinson's disease: A complex and evolving picture

Fasano A, Canning CG, Hausdorff JM, Lord S, Rochester L.

Mov Disord. 2017 Nov;32(11):1524-1536. doi: 10.1002/mds.27195. Epub 2017 Oct 25.

Relationship between Apolipoprotein Superfamily and Parkinson's Disease

Li L, Liu MS, Li GQ, Tang J, Liao Y, Zheng Y, Guo TL, Kang X, Yuan MT.

Chin Med J (Engl). 2017 Nov 5;130(21):2616-2623. doi: 10.4103/0366-6999.217092.

Bioactivity of Olive Oil Phenols in Neuroprotection

Angeloni C, Malaguti M, Barbalace MC, Hrelia S.

Int J Mol Sci. 2017 Oct 25;18(11):2230. doi: 10.3390/ijms18112230.

What would Dr. James parkinson think today? Mutations in beta-glucocerebrosidase and risk of Parkinson's disease

Standaert DG.

Mov Disord. 2017 Oct;32(10):1341-1342. doi: 10.1002/mds.27206.

Amnestic dementia impairment in Parkinson's disease: The role of body composition, ageing and insulin resistance

Schelp AO, Mendes-Chiloff CL, Paduan VC, Corrente JE, Vieira A, Marchette JCN, de Souza JT, Luvizuto GJ, Nogueira CR, Bazan R.

Clin Nutr ESPEN. 2017 Aug;20:47-51. doi: 10.1016/j.clnesp.2017.03.006. Epub 2017 May 3.

Pharmacotherapy of Cardiovascular Autonomic Dysfunction in Parkinson Disease

Shibao CA, Kaufmann H.

CNS Drugs. 2017 Nov;31(11):975-989. doi: 10.1007/s40263-017-0473-5.

Oxidative Stress: Mechanistic Insights into Inherited Mitochondrial Disorders and Parkinson's Disease

Al Shahrani M, Heales S, Hargreaves I, Orford M.

J Clin Med. 2017 Oct 27;6(11):100. doi: 10.3390/jcm6110100.

Cognitive and Neuropsychiatric Features of Early Parkinson's Disease

Getz SJ, Levin B.

Arch Clin Neuropsychol. 2017 Nov 1;32(7):769-785. doi: 10.1093/arclin/acx091.

The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases

Sommer A, Winner B, Prots I.

Mol Neurodegener. 2017 Oct 27;12(1):78. doi: 10.1186/s13024-017-0222-8.

Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study

Cumming K, Macleod AD, Myint PK, Counsell CE.

Neurology. 2017 Nov 28;89(22):2254-2261. doi: 10.1212/WNL.0000000000004691. Epub 2017 Oct 27.

Retrospection on the Role of Soluble Guanylate Cyclase in Parkinson's Disease

Ghanta M, Panchanathan E, Lakkakula BVKS, Narayanaswamy A.

J Pharmacol Pharmacother. 2017 Jul-Sep;8(3):87-91. doi: 10.4103/jpp.JPP_45_17.

Structural abnormality of substantia nigra induced by methamphetamine abuse

Rumpf JJ, Albers J, Fricke C, Mueller W, Classen J.

Mov Disord. 2017 Dec;32(12):1784-1788. doi: 10.1002/mds.27205. Epub 2017 Oct 30.

Cognitive impairment in progressive supranuclear palsy is associated with tau burden

Koga S, Parks A, Kasanuki K, Sanchez-Contreras M, Baker MC, Josephs KA, Ahlskog JE, Uitti RJ, Graff-Radford N, van Gerpen JA, Wszolek ZK, Rademakers R, Dickson DW.

Mov Disord. 2017 Dec;32(12):1772-1779. doi: 10.1002/mds.27198. Epub 2017 Oct 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias